SEC Form 4 · accession 0001104659-15-046936
ALPINE IMMUNE SCIENCES, INC. · ALPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Jun 19, 2015
Accepted (ET)
Jun 23, 2015 · 2:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626199
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Jun 19, 2015 | P | 11,700 | $14.6659 | A | 32,100 | D | |
| Common stock | Jun 22, 2015 | P | 5,500 | $14.7479 | A | 37,600 | D | |
| Common stockF1 | Jun 22, 2015 | C | 283,390 | — | A | 320,990 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series 2 convertible preferred stockF1 | — | Jun 22, 2015 | C | 818,714 | D | — | — | Common stock | 283,390 | 0 | D |
Explanation of responses
- F1The Series 2 convertible preferred stock converted into common stock on a 2.889-for-1 basis and had no expiration date.